Report Overview
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
The global PD-L1 Biomarker Testing Platform market size was estimated at USD 1470 million in 2023 and is projected to reach USD 2222.48 million by 2032, exhibiting a CAGR of 4.70% during the forecast period.
North America PD-L1 Biomarker Testing Platform market size was estimated at USD 414.52 million in 2023, at a CAGR of 4.03% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global PD-L1 Biomarker Testing Platform market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-L1 Biomarker Testing Platform Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-L1 Biomarker Testing Platform market in any manner.
Global PD-L1 Biomarker Testing Platform Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Roche
Market Segmentation (by Type)
PD-L1(22C3)
PD-L1(28-8)
PD-L1(SP142)
PD-L1(SP263)
Other
Market Segmentation (by Application)
Hospital
Diagnostic Center
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD-L1 Biomarker Testing Platform Market
Overview of the regional outlook of the PD-L1 Biomarker Testing Platform Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD-L1 Biomarker Testing Platform
1.2 Key Market Segments
1.2.1 PD-L1 Biomarker Testing Platform Segment by Type
1.2.2 PD-L1 Biomarker Testing Platform Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-L1 Biomarker Testing Platform Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-L1 Biomarker Testing Platform Market Competitive Landscape
3.1 Global PD-L1 Biomarker Testing Platform Revenue Market Share by Company (2019-2025)
3.2 PD-L1 Biomarker Testing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company PD-L1 Biomarker Testing Platform Market Size Sites, Area Served, Product Type
3.4 PD-L1 Biomarker Testing Platform Market Competitive Situation and Trends
3.4.1 PD-L1 Biomarker Testing Platform Market Concentration Rate
3.4.2 Global 5 and 10 Largest PD-L1 Biomarker Testing Platform Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 PD-L1 Biomarker Testing Platform Value Chain Analysis
4.1 PD-L1 Biomarker Testing Platform Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of PD-L1 Biomarker Testing Platform Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-L1 Biomarker Testing Platform Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-L1 Biomarker Testing Platform Market Size Market Share by Type (2019-2025)
6.3 Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type (2019-2025)
7 PD-L1 Biomarker Testing Platform Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-L1 Biomarker Testing Platform Market Size (M USD) by Application (2019-2025)
7.3 Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Application (2019-2025)
8 PD-L1 Biomarker Testing Platform Market Segmentation by Region
8.1 Global PD-L1 Biomarker Testing Platform Market Size by Region
8.1.1 Global PD-L1 Biomarker Testing Platform Market Size by Region
8.1.2 Global PD-L1 Biomarker Testing Platform Market Size Market Share by Region
8.2 North America
8.2.1 North America PD-L1 Biomarker Testing Platform Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-L1 Biomarker Testing Platform Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-L1 Biomarker Testing Platform Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-L1 Biomarker Testing Platform Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-L1 Biomarker Testing Platform Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Agilent Technologies
9.1.1 Agilent Technologies PD-L1 Biomarker Testing Platform Basic Information
9.1.2 Agilent Technologies PD-L1 Biomarker Testing Platform Product Overview
9.1.3 Agilent Technologies PD-L1 Biomarker Testing Platform Product Market Performance
9.1.4 Agilent Technologies PD-L1 Biomarker Testing Platform SWOT Analysis
9.1.5 Agilent Technologies Business Overview
9.1.6 Agilent Technologies Recent Developments
9.2 Roche
9.2.1 Roche PD-L1 Biomarker Testing Platform Basic Information
9.2.2 Roche PD-L1 Biomarker Testing Platform Product Overview
9.2.3 Roche PD-L1 Biomarker Testing Platform Product Market Performance
9.2.4 Roche PD-L1 Biomarker Testing Platform SWOT Analysis
9.2.5 Roche Business Overview
9.2.6 Roche Recent Developments
10 PD-L1 Biomarker Testing Platform Regional Market Forecast
10.1 Global PD-L1 Biomarker Testing Platform Market Size Forecast
10.2 Global PD-L1 Biomarker Testing Platform Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-L1 Biomarker Testing Platform Market Size Forecast by Country
10.2.3 Asia Pacific PD-L1 Biomarker Testing Platform Market Size Forecast by Region
10.2.4 South America PD-L1 Biomarker Testing Platform Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-L1 Biomarker Testing Platform by Country
11 Forecast Market by Type and by Application (2025-2032)
11.1 Global PD-L1 Biomarker Testing Platform Market Forecast by Type (2025-2032)
11.2 Global PD-L1 Biomarker Testing Platform Market Forecast by Application (2025-2032)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-L1 Biomarker Testing Platform Market Size Comparison by Region (M USD)
Table 5. Global PD-L1 Biomarker Testing Platform Revenue (M USD) by Company (2019-2025)
Table 6. Global PD-L1 Biomarker Testing Platform Revenue Share by Company (2019-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing Platform as of 2022)
Table 8. Company PD-L1 Biomarker Testing Platform Market Size Sites and Area Served
Table 9. Company PD-L1 Biomarker Testing Platform Product Type
Table 10. Global PD-L1 Biomarker Testing Platform Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of PD-L1 Biomarker Testing Platform
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. PD-L1 Biomarker Testing Platform Market Challenges
Table 18. Global PD-L1 Biomarker Testing Platform Market Size by Type (M USD)
Table 19. Global PD-L1 Biomarker Testing Platform Market Size (M USD) by Type (2019-2025)
Table 20. Global PD-L1 Biomarker Testing Platform Market Size Share by Type (2019-2025)
Table 21. Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type (2019-2025)
Table 22. Global PD-L1 Biomarker Testing Platform Market Size by Application
Table 23. Global PD-L1 Biomarker Testing Platform Market Size by Application (2019-2025) & (M USD)
Table 24. Global PD-L1 Biomarker Testing Platform Market Share by Application (2019-2025)
Table 25. Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Application (2019-2025)
Table 26. Global PD-L1 Biomarker Testing Platform Market Size by Region (2019-2025) & (M USD)
Table 27. Global PD-L1 Biomarker Testing Platform Market Size Market Share by Region (2019-2025)
Table 28. North America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2025) & (M USD)
Table 29. Europe PD-L1 Biomarker Testing Platform Market Size by Country (2019-2025) & (M USD)
Table 30. Asia Pacific PD-L1 Biomarker Testing Platform Market Size by Region (2019-2025) & (M USD)
Table 31. South America PD-L1 Biomarker Testing Platform Market Size by Country (2019-2025) & (M USD)
Table 32. Middle East and Africa PD-L1 Biomarker Testing Platform Market Size by Region (2019-2025) & (M USD)
Table 33. Agilent Technologies PD-L1 Biomarker Testing Platform Basic Information
Table 34. Agilent Technologies PD-L1 Biomarker Testing Platform Product Overview
Table 35. Agilent Technologies PD-L1 Biomarker Testing Platform Revenue (M USD) and Gross Margin (2019-2025)
Table 36. Agilent Technologies PD-L1 Biomarker Testing Platform SWOT Analysis
Table 37. Agilent Technologies Business Overview
Table 38. Agilent Technologies Recent Developments
Table 39. Roche PD-L1 Biomarker Testing Platform Basic Information
Table 40. Roche PD-L1 Biomarker Testing Platform Product Overview
Table 41. Roche PD-L1 Biomarker Testing Platform Revenue (M USD) and Gross Margin (2019-2025)
Table 42. Roche PD-L1 Biomarker Testing Platform SWOT Analysis
Table 43. Roche Business Overview
Table 44. Roche Recent Developments
Table 45. Global PD-L1 Biomarker Testing Platform Market Size Forecast by Region (2025-2032) & (M USD)
Table 46. North America PD-L1 Biomarker Testing Platform Market Size Forecast by Country (2025-2032) & (M USD)
Table 47. Europe PD-L1 Biomarker Testing Platform Market Size Forecast by Country (2025-2032) & (M USD)
Table 48. Asia Pacific PD-L1 Biomarker Testing Platform Market Size Forecast by Region (2025-2032) & (M USD)
Table 49. South America PD-L1 Biomarker Testing Platform Market Size Forecast by Country (2025-2032) & (M USD)
Table 50. Middle East and Africa PD-L1 Biomarker Testing Platform Market Size Forecast by Country (2025-2032) & (M USD)
Table 51. Global PD-L1 Biomarker Testing Platform Market Size Forecast by Type (2025-2032) & (M USD)
Table 52. Global PD-L1 Biomarker Testing Platform Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Industrial Chain of PD-L1 Biomarker Testing Platform
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-L1 Biomarker Testing Platform Market Size (M USD), 2019-2032
Figure 5. Global PD-L1 Biomarker Testing Platform Market Size (M USD) (2019-2032)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. PD-L1 Biomarker Testing Platform Market Size by Country (M USD)
Figure 10. Global PD-L1 Biomarker Testing Platform Revenue Share by Company in 2023
Figure 11. PD-L1 Biomarker Testing Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by PD-L1 Biomarker Testing Platform Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global PD-L1 Biomarker Testing Platform Market Share by Type
Figure 15. Market Size Share of PD-L1 Biomarker Testing Platform by Type (2019-2025)
Figure 16. Market Size Market Share of PD-L1 Biomarker Testing Platform by Type in 2022
Figure 17. Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Type (2019-2025)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global PD-L1 Biomarker Testing Platform Market Share by Application
Figure 20. Global PD-L1 Biomarker Testing Platform Market Share by Application (2019-2025)
Figure 21. Global PD-L1 Biomarker Testing Platform Market Share by Application in 2022
Figure 22. Global PD-L1 Biomarker Testing Platform Market Size Growth Rate by Application (2019-2025)
Figure 23. Global PD-L1 Biomarker Testing Platform Market Size Market Share by Region (2019-2025)
Figure 24. North America PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 25. North America PD-L1 Biomarker Testing Platform Market Size Market Share by Country in 2023
Figure 26. U.S. PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 27. Canada PD-L1 Biomarker Testing Platform Market Size (M USD) and Growth Rate (2019-2025)
Figure 28. Mexico PD-L1 Biomarker Testing Platform Market Size (Units) and Growth Rate (2019-2025)
Figure 29. Europe PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 30. Europe PD-L1 Biomarker Testing Platform Market Size Market Share by Country in 2023
Figure 31. Germany PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 32. France PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 33. U.K. PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 34. Italy PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 35. Russia PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 36. Asia Pacific PD-L1 Biomarker Testing Platform Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific PD-L1 Biomarker Testing Platform Market Size Market Share by Region in 2023
Figure 38. China PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 39. Japan PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 40. South Korea PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 41. India PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 42. Southeast Asia PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 43. South America PD-L1 Biomarker Testing Platform Market Size and Growth Rate (M USD)
Figure 44. South America PD-L1 Biomarker Testing Platform Market Size Market Share by Country in 2023
Figure 45. Brazil PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 46. Argentina PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 47. Columbia PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 48. Middle East and Africa PD-L1 Biomarker Testing Platform Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa PD-L1 Biomarker Testing Platform Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 51. UAE PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 52. Egypt PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 53. Nigeria PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 54. South Africa PD-L1 Biomarker Testing Platform Market Size and Growth Rate (2019-2025) & (M USD)
Figure 55. Global PD-L1 Biomarker Testing Platform Market Size Forecast by Value (2019-2032) & (M USD)
Figure 56. Global PD-L1 Biomarker Testing Platform Market Share Forecast by Type (2025-2032)
Figure 57. Global PD-L1 Biomarker Testing Platform Market Share Forecast by Application (2025-2032)
